SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 204.18 |
| Enterprise Value ($M) | 156.85 |
| Book Value ($M) | 184.75 |
| Book Value / Share | 2.85 |
| Price / Book | 1.11 |
| NCAV ($M) | 1.05 |
| NCAV / Share | 0.02 |
| Price / NCAV | 193.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.59 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.92 |
| Current Ratio | 9.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 176.99 |
| Assets | 360.69 |
| Liabilities | 175.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.23 |
| Operating Income | -125.18 |
| Net Income | -136.67 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -88.35 |
| Cash from Investing | 61.13 |
| Cash from Financing | -9.72 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Bain Capital Life Sciences Opportunities III, LP | 6.60 | ||
| 13G | Boxer Capital, LLC | 5.80 | ||
| 13G | Casdin Capital, LLC | 6.08 | 61.88 | |
| 13G | Venrock Healthcare Capital Partners III, L.P. | 5.40 | ||
| 13G/A | Fmr Llc | 6.04 | -5.51 | |
| 13G/A | Versant Venture Capital VI, L.P. | 19.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,800 | 27,308 | 24.90 | |
| 14,752 | 28,542 | 51.69 | |
| 32,513 | 23,882 | 136.14 | |
| 8,597 | 17,071 | 50.36 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INZY – Inozyme Pharma, Inc. | IOBT – IO Biotech, Inc. |
| IONS – Ionis Pharmaceuticals, Inc. | IRWD – Ironwood Pharmaceuticals, Inc. |
| ITCI – Intra-Cellular Therapies, Inc. |
Financial data and stock pages provided by
Fintel.io